Reply to ‘NALIRIFOX in the frontline for metastatic pancreatic cancer: evidence beyond NAPOLI 3’

Authors: Christopher Nevala-Plagemann, Thierry Conroy, Ignacio Garrido-Laguna

Published: 2024-10-25

DOI: 10.1038/s41571-024-00953-4

Source: Full article

---

Abstract

No abstract found.